Open Access
Table 2
Prevalence estimates of E. bieneusi infection, and estimated numbers of infected people in 34 countries.
Country and continent (No.) | No. examined | No. positive | % (95% CI) | Estimated population size 2021 (thousands) | Estimated number of infected people (95% CI) |
---|---|---|---|---|---|
Australia (3) | 845 | 48 | 2.97% (0.56–14.35) | 25,921 | 770 (145–3,720) |
Oceania
|
845 |
48 |
4.52% (0.01–16.52) |
44,492 |
2,011 (4–7,350) |
Argentina (1) | 143 | 16 | 11.19% (6.97–17.48) | 45,277 | 5,066 (3,156–7,914) |
Brazil (2) | 206 | 27 | 15.73% (7.16–31.13) | 214,326 | 33,713 (15,346–66,720) |
Peru (1) | 2672 | 105 | 3.93% (3.26–4.74) | 33,715 | 1,325 (1,099–1,598) |
South America
|
3021 |
148 |
10.99% (4.12–20.63) |
434,254 |
47,724 (17,891–89,586) |
China (16) | 9826 | 328 | 3.66% (1.81–7.25) | 1,425,893 | 52,188 (25,809–103,377) |
Malaysia (1) | 447 | 67 | 14.99% (11.97–18.61) | 33,574 | 5,033 (4,019–6,248) |
Myanmar (1) | 172 | 15 | 8.72% (5.33–13.96) | 53,798 | 4,691 (2,867–7,510) |
Thailand (5) | 2049 | 111 | 3.18% (1.37–7.22) | 71,601 | 2,277 (981–5,170) |
East and South-East Asia
|
12494 |
521 |
5.22% (3.19–7.71) |
2,339,493 |
122,121 (74,629–180,374) |
Bangladesh (1) | 299 | 19 | 6.35% (4.09–9.75) | 169,356 | 10,754 (6,927–16,512) |
India (4) | 943 | 144 | 9.48% (3.68–22.31) | 1,407,564 | 133,437 (51,798–314,028) |
Central and South Asia
|
1242 |
163 |
4.67% (3.08–7.01) |
2,065,350 |
96,451 (63,612–144,781) |
Iran (3) | 834 | 22 | 2.93% (1.24–6.80) | 87,923 | 2,576 (1,090–5,979) |
Türkiye (2) | 223 | 14 | 6.28% (3.75–10.32) | 84,775 | 5,324 (3,179–8,749) |
Yemen (1) | 402 | 57 | 14.18 (11.10–17.94) | 32,982 | 4,677 (3,661–5,917) |
North Africa and Western Asia
|
1459 |
93 |
5.60% (2.39–10.04) |
545,471 |
30,546 (13,036–54,765) |
Cameroon (2) |
1018 |
37 |
3.88% (2.28–6.53) |
27,199 |
1,055 (620–1,776) |
Egypt (2) | 685 | 47 | 9.62% (3.30–24.93) | 109,262 | 10,511 (3,606–27,239) |
Gabon (1) | 758 | 22 | 3.04% (2.06–4.46) | 2,341 | 71 (48–104) |
Guinea-Bissau (1) | 52 | 3 | 5.77% (1.87–16.42) | 2,061 | 119 (39–338) |
Mali (1) |
61 |
8 |
13.11% (6.70–24.10) |
21,905 |
2,872 (1,468–5,279) |
Mozambique (1) |
1247 |
9 |
0.72% (0.38–1.38) |
32,077 |
231 (122–443) |
Niger (1) | 228 | 24 | 10.53% (7.16–15.22) | 25,253 | 2,659 (1,808–3,844) |
Nigeria (2) | 325 | 18 | 5.54% (3.52–8.62) | 213,401 | 11,822 (7,512–18,395) |
South Africa (1) | 170 | 56 | 32.94% (26.30–40.35) | 59,392 | 19,564 (15,620–23,965) |
Sao Tome and Principe (1) | 348 | 26 | 7.47% (5.14–10.75) | NA | NA |
Uganda (1) | 2446 | 422 | 17.25% (15.81–18.80) | 45,854 | 7,910 (7,250–8,621) |
Vietnam (1) | 42 | 3 | 7.14% (2.32–19.93) | 97,468 | 6,959 (2,261–19,425) |
Zimbabwe (1) | 202 | 14 | 6.93% (4.15–11.36) | 15,994 | 1,108 (664–1,817) |
Africa
|
7582 |
689 |
8.06% (4.91–11.92) |
1,137,939 |
91,717 (55,872–135,642) |
Czechia (3) |
560 |
188 |
31.08% (20.15–44.63) |
10,511 |
3,267 (2,118–4,691) |
France (3) |
599 |
11 |
5.04% (1.05–20.90) |
64,531 |
3252 (678–13,487) |
Germany (2) |
59 |
23 |
41.66% (23.28–62.70) |
83,409 |
34,748 (19,418–52,297) |
Poland (1) | 86 | 5 | 5.81% (2.44–13.22) | 38,308 | 2,226 (935–5,064) |
Portugal (1) | 860 | 69 | 8.02% (6.39–10.04) | 10,290 | 825 (658–1,033) |
Russia (1) | 159 | 30 | 18.87% (13.52–25.71) | 145,103 | 27,381 (19,618–37,306) |
Slovakia (2) | 233 | 20 | 8.33% (4.37–15.30) | 5,448 | 454 (238–834) |
Spain (3) | 403 | 34 | 6.96% (2.31–19.16) | 47,487 | 3,305 (1,097–9,099) |
Europe
|
4,413 |
718 |
14.70% (8.21–22.68) |
745,174 |
109,540 (61,178–169,005) |
World | 31,644 | 2291 | 6.59% (4.97–8.68) | 7,909,295 | 521,222 (393,092–686,526) |
CI: confidence interval; NA: not applicable.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.